Lifeward Ltd. (LFWD) SEC filings

LFWDNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/3066% below fair value

$4.06−1.66 (-29.02%)

Close on Nov 13, 2026Market cap $11.50MP/E –Yield –

SEC filings

40 of Lifeward's most recent filings on SEC EDGAR

Document	Form	Period	Filed	Source
Current report	8-K	Nov 13, 2026	Nov 13, 2026	SEC EDGAR
Quarterly report	10-Q	Sep 30, 2026	Nov 13, 2026	SEC EDGAR
Current report	8-K	Oct 30, 2026	Nov 5, 2026	SEC EDGAR
Current report	8-K	Oct 27, 2026	Oct 27, 2026	SEC EDGAR
Current report	8-K	Oct 4, 2026	Oct 8, 2026	SEC EDGAR
Current report	8-K	Oct 1, 2026	Oct 1, 2026	SEC EDGAR
Proxy statement	DEF 14A	Sep 25, 2026	Sep 25, 2026	SEC EDGAR
Current report	8-K	Sep 15, 2026	Sep 15, 2026	SEC EDGAR
Current report	8-K	Sep 8, 2026	Sep 8, 2026	SEC EDGAR
Current report	8-K	Aug 31, 2026	Aug 31, 2026	SEC EDGAR
Current report	8-K	Aug 14, 2026	Aug 20, 2026	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2026	Aug 14, 2026	SEC EDGAR
Current report	8-K	Aug 10, 2026	Aug 14, 2026	SEC EDGAR
Current report	8-K	Jun 30, 2026	Jul 7, 2026	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2026	May 20, 2026	SEC EDGAR
Current report	8-K	May 18, 2026	May 19, 2026	SEC EDGAR
Current report	8-K	May 15, 2026	May 15, 2026	SEC EDGAR
Current report	8-K	Apr 20, 2026	Apr 23, 2026	SEC EDGAR
Current report	8-K	Mar 30, 2026	Mar 31, 2026	SEC EDGAR
Current report	8-K	Mar 25, 2026	Mar 25, 2026	SEC EDGAR
Current report	8-K	Mar 17, 2026	Mar 20, 2026	SEC EDGAR
Annual report	10-K	Dec 31, 2025	Mar 18, 2026	SEC EDGAR
Current report	8-K	Mar 18, 2026	Mar 18, 2026	SEC EDGAR
Current report	8-K	Mar 12, 2026	Mar 13, 2026	SEC EDGAR
Current report	8-K	Mar 10, 2026	Mar 11, 2026	SEC EDGAR
Current report	8-K	Feb 24, 2026	Mar 2, 2026	SEC EDGAR
Current report	8-K	Feb 24, 2026	Feb 27, 2026	SEC EDGAR
Current report	8-K	Feb 19, 2026	Feb 25, 2026	SEC EDGAR
Current report	8-K	Feb 12, 2026	Feb 19, 2026	SEC EDGAR
Current report	8-K	Feb 3, 2026	Feb 9, 2026	SEC EDGAR
Current report	8-K	Jan 28, 2026	Jan 28, 2026	SEC EDGAR
Current report	8-K	Jan 12, 2026	Jan 13, 2026	SEC EDGAR
Current report	8-K	Jan 6, 2026	Jan 6, 2026	SEC EDGAR
Current report	8-K	Dec 17, 2025	Dec 19, 2025	SEC EDGAR
Proxy statement	DEF 14A	Dec 1, 2025	Dec 1, 2025	SEC EDGAR
Quarterly report	10-Q	Sep 30, 2025	Nov 14, 2025	SEC EDGAR
Current report	8-K	Nov 14, 2025	Nov 14, 2025	SEC EDGAR
Current report	8-K	Oct 16, 2025	Oct 16, 2025	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2025	Aug 14, 2025	SEC EDGAR
Current report	8-K	Aug 14, 2025	Aug 14, 2025	SEC EDGAR

Where these numbers come from

Parsed from the XBRL in Lifeward's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-12 reverse split on Feb 24, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is LFWD.

Compare: LFWD vs MYO · LFWD vs ZJYL · LFWD vs APT · LFWD vs MLSS · LFWD vs HYPR

Revenue growth-14.1% · median 8.6%

Gross margin31.5% · median 61.4%

Operating margin-121.5% · median -30.9%

Net margin-155.4% · median -35.7%

Company	Revenue	Growth
APT	$63.73M	+7.8%
MYO	$45.50M	+9.3%
LFWD	$21.06M	-14.1%
HYPR	$19.06M	+80.0%
MLSS	$9.28M	+3.9%
ZJYL	–	–

Company

Next earnings (est.): Mar 17, 2027, before open
Exchange: Nasdaq
Industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies
Fiscal year ends: December 31
Employees: 81
Held by institutions: 1.1%
Auditor: KOST FORER GABBAY & KASIERER
SEC CIK: 1607962

Advertisement
300 × 250

See a number that looks wrong?